All content here is for general education only
After setbacks in internal oral GLP-1 development, Pfizer moved to strengthen its position through acquisition activity, including its move for Metsera and its next-generation obesity portfolio
The animal literature is unusually consistent, though: nearly every published in vivo study used 5 mg/kg per injection, given three times on alternate days (days 1, 3, and 5, or days 14, 16, and 18 in the pulmonary fibrosis model), with effects tracked over the following three to four weeks
D, Histologic image (hematoxylin-eosin original magnification 100) of the lesion in Figure 3B, showing atypical pigmented keratinocytes at the dermal-epidermal junction and solar elastosis in the dermis
For the best detail, clarity, and reproduction of your uploaded image, we recommend vector files or a print-ready PDF
Comprehensive Initial Consultation Your care begins with a complete medical review so the team can understand your history and determine if GLP-1 therapy is the right fit